Overview
- Lohfink told Bild on Friday that she has pushed a planned December operation into 2027 because she is physically and mentally exhausted from repeated surgeries and full anaesthetics.
- She continues to suffer daily pain, open wounds that need regular care, and limits on normal activities such as sitting, which her coverage says have driven the decision to pause surgery.
- Her treating physician, Dr. Andreas Dorow of the Dorow Clinic, says more surgical interventions will be necessary to remove remaining Aquafilling material and that the process is a prolonged, multi‑stage effort.
- A multi‑hour operation in Zürich in January 2026 removed part of the injected filler, but reports indicate residual gel, nodules and encapsulations still need surgical excision to reduce infection and inflammation risks.
- The case highlights medical risks tied to Aquafilling filler use, the long recovery and psychological toll on patients, and signals that Lohfink faces a drawn‑out treatment course and continued wound care through 2027.